FDA.reportPublic FDA data

Viberzi 100 MG Oral Tablet

RxCUI
1719766
RxNorm name
Viberzi 100 MG Oral Tablet
Display name
Viberzi 100 MG Oral Tablet
Full name
Viberzi 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ViberziELUXADOLINEAllergan, Inc.7821bd40-4c84-4984-951b-6436ae20421a2024-07-16Warnings, Adverse reactionsExact identifier
rxcui: 1719766

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7821bd40-4c84-4984-951b-6436ae20421aViberzi 100 MG Oral Tablet [PSN] · eluxadoline 100 MG Oral Tablet [Viberzi] [SBD] · Viberzi 100 MG Oral Tablet [SY]327These highlights do not include all the information needed to use VIBERZI safely and effectively. See full prescribing information for VIBERZI . VIBERZI (eluxadoline) tablets, for oral use , C IV Initial U.S. Approval: 201520240716